Investigator-initiated clinical trial for progressive supranuclear palsy using an anti-cholinergic drug
Not Applicable
Recruiting
- Conditions
- Progressive supranuclear palsy
- Registration Number
- JPRN-UMIN000036522
- Lead Sponsor
- 1) Department of Neurology, Gifu University Graduate School of Medicine, 2) National Hospital Organization, Higashi Nagoya Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Not provided
Exclusion Criteria
1) attending other clinical trials 2) alcohol dependence or drug abuser 3) psychiatric disorder 4) allergy for anti-cholinergic drugs 5) severe liver or renal dysfunction 6) effective for levodopa, and/or using following drugs: anti-psychiatric agents, anti-epileptic drugs, acethycholine esterase inhibitor, memantine, immunosuppressant, corticosteroids, anti-coagulant, lithium, or anti-cholinergic drug 7) not suitable for clinical trial judged by principal investigator or researchers.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method